“american-society-of-clinical-oncology” Archives

in
Entry Author Date Location
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More 05/17/19 National
Eli Lilly Makes an $8B Cancer Genetics Bet with Loxo Acquisition 01/07/19 Indiana
BCMA Day: At ASH ‘18, Cell Therapies For Myeloma Take Center Stage 12/04/18 National
FDA Puts Mersana Cancer Study on Partial Hold After Patient Death 07/19/18 Boston
ASCO Wrap: Cancer Combos, Precision Meds, Stock Movers & More 06/05/18 National
Loxo Unveils More Data, Paves a Path Forward In Precision Oncology 06/02/18 National
IDO Don’ts: After Immunotherapy Failure, Experts Say Slow Down 05/31/18 National
Ahead of ASCO, Merck Touts Another Win for Lung Cancer Drug Combo 05/23/18 New York
Bio Roundup: IDO Fallout, Express Scripts Dumps Amgen, Isaly Out & More 05/04/18 National
BioCryst, Idera Plan Merger in Tie-Up of Rare Disease Drug Developers 01/22/18 Raleigh Durham
Exact, Spectrum, PerBlue, & More: This Week’s Wisconsin Watchlist 01/19/18 Wisconsin
Checkmate Pharma Clinches $27M for More Studies in Skin Cancer 06/15/17 Boston
Precision Steps: Can Loxo Drug Help Broaden Use of Cancer DNA Tests? 06/03/17 National
Bio Roundup: ASCO Combo Frenzy, Maine’s Free DNA Tests, Sema4 & More 06/02/17 National
On ASCO’s Eve, Experts Fret Over Backlash to Cancer Combo Frenzy 05/30/17 National
Biotech Roundup: ASCO, BIO, Drug Setbacks, Incubators & More 06/10/16 National
Houston Biotech Esperance Eyes $40M Raise to Fund Cancer Drug Push 03/30/16 Texas
Medical Test Validity Will Be Debated In 2016: 5 Storylines To Watch 01/14/16 Wisconsin
Pharma Plays The “Value” Card: Drug Spending Then And Now 09/14/15 National
East Coast Biotech Roundup: Seres, Editas, PureTech, Pronutria & More 05/29/15 Boston
East Coast Biotech Roundup: Vertex, Moderna, Sage, ASCO & More 05/15/15 Boston
Gilead Exec: More Value in Quick Hep C Cure than Cancer Treatments 02/10/15 San Francisco
Cancer Drug Developer G1 Therapeutics Closes $33M Series B Round 02/05/15 Raleigh Durham
Beg, Borrow, or Steal: Accessing Unaffordable Science Journals 11/10/14 National
East Coast Biotech Roundup: Accelerate LI, ASCO, Akebia, & More 06/09/14 Boston
Post-IPO Biotechs Have News, But Big Pharma Drives the ASCO Boat 06/06/14 Boston
Tesaro Climbs on Phase 3 Data for Nausea Drug 05/12/14 Boston
Genentech Joins “What’s Hot in Cancer Immunotherapy” Apr. 22 03/07/14 Seattle
Juno Therapeutics Grabs $120M to Coax Immune System to Fight Cancer 12/03/13 Seattle
Genentech Does it Again, Wins FDA Approval for ‘Son of Rituxan’ 11/01/13 San Francisco
Page 1 of 5 next page »